Severe falciparum malaria with shock (algid malaria)
Tropical sepsis · Shock / Sepsis
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Life-threatening Plasmodium falciparum infection complicated by circulatory shock ('algid malaria'), often with concurrent Gram-negative bacteraemia, requiring parenteral artesunate, resuscitation and antibacterial cover.
Figures & algorithms
Red flags
- Impaired consciousness (cerebral malaria)
- Shock with high parasitaemia
- Hypoglycaemia
- Acidosis / rising lactate
- Oliguria, jaundice, bleeding (multi-organ involvement)
Assessment
Differential diagnosis
- Severe falciparum malaria (algid)
- Concurrent bacterial (Gram-negative) sepsis
- Other tropical sepsis (typhoid, leptospirosis)
- Viral haemorrhagic fever
- Dengue shock syndrome
Investigations
- Thick and thin blood films + rapid antigen test; quantify parasitaemia
- Blood cultures (co-existing bacteraemia common)
- Glucose (hypoglycaemia), lactate, blood gas
- FBC, U&E, LFTs, coagulation, G6PD if considering primaquine
- CXR (ARDS) and fluid-responsiveness assessment
Management
- Confirm diagnosis and severity (parasitaemia, end-organ dysfunction, shock)
- Start IV artesunate without delay — do not wait for species confirmation if high suspicion
- Resuscitate shock cautiously — malaria patients tolerate large fluid boluses poorly (ARDS risk); use vasopressors early
- Add empirical broad-spectrum antibiotics for probable concurrent bacterial sepsis
- Check and correct hypoglycaemia frequently
- Monitor for and treat complications: cerebral malaria, AKI, ARDS, DIC, haemolysis
- Watch for post-artesunate delayed haemolysis after treatment
- Discuss with infectious diseases and admit to critical care
Drugs & doses
Artesunate — 2.4 mg/kg IV at 0, 12 and 24 h, then once daily (drug of choice for severe malaria)
Ceftriaxone — 2 g IV (empirical cover for co-existing Gram-negative bacteraemia)
Noradrenaline — 0.05-0.5 mcg/kg/min IV titrated to MAP ≥65 mmHg
10% glucose — IV to correct/prevent hypoglycaemia
Balanced crystalloid — cautious boluses guided by responsiveness (avoid over-filling)
Disposition
Critical care admission with infectious-diseases input; monitor for delayed haemolysis and complete the oral antimalarial course on recovery.
Complications & pitfalls
- Cerebral malaria
- Acute kidney injury (blackwater fever)
- ARDS
- Hypoglycaemia
- DIC and delayed post-artesunate haemolysis
Exam pearls
- Shock in falciparum malaria implies co-existing bacterial sepsis until proven otherwise — give antibiotics
- Be conservative with fluids; these patients are prone to pulmonary oedema/ARDS
- Artesunate is superior to quinine and should not be delayed
- Check glucose repeatedly — hypoglycaemia is common and treatable
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.
